Is Berberine Really a “Natural Ozempic”?

Often labeled a “natural Ozempic,” berberine is widely discussed as a metabolic aid. Yet research suggests its influence may lie deeper.

In recent years, berberine has gained significant attention as a supposed “natural way” to support metabolism. Discussions on social media frequently compare the compound with incretin drugs, and it is sometimes labeled “plant-based Ozempic.” These comparisons suggest that berberine works through a clear and predictable biological pathway.

However, a new scientific review indicates that this popular portrayal is overly simplistic. According to the authors, the available research does not support the idea that berberine acts through a straightforward mechanism or produces uniform metabolic effects.

Researchers from Wroclaw Medical University explain that berberine is an alkaloid that does not function like a hormone based medication and does not target a single receptor. Instead, its influence on metabolism appears indirect and broadly distributed, with outcomes that depend heavily on conditions inside the intestine.

Metabolism begins in the intestine

Experimental evidence most strongly supports berberine’s role in the gut, particularly in relation to intestinal microbes, inflammation, and the stability of the intestinal barrier. These processes appear to be where the compound has its most measurable biological effects.

“The best understood is the microbiotic level and its impact on the intestinal barrier and inflammatory processes,” says Anna Duda-Madej, MD, PhD. “Therefore, the gut-brain axis remains the most promising, but its clinical significance still requires a lot of research,” she adds.

In practical terms, this suggests that berberine does not directly regulate metabolism. Instead, it influences the biological environment in which metabolic processes take place.

Why are the effects so different?

One major conclusion of the review is that responses to berberine differ widely among individuals. The compound interacts closely with gut microbiota, and its effects depend heavily on the composition and activity of these microbial communities.

“Berberine does not act in a microbiological vacuum. Its effects are largely microbiota-dependent,” the researcher notes.

Because gut microbiota vary from person to person, the dominant effects of berberine can also differ. In some individuals, anti-inflammatory actions may be more prominent. In others, the compound may primarily support the intestinal barrier or influence metabolic pathways.

People who recently completed antibiotic treatment or who have disrupted gut microbiota may experience weaker or slower responses. This variability helps explain why berberine does not produce consistent results across all individuals.

Bioavailability as an element of biological logic

The review also addresses a commonly cited limitation of berberine: its low systemic bioavailability. When taken orally, only a small amount reaches the bloodstream.

However, the researchers suggest that this characteristic may actually support its biological activity in the intestine.

“Low bioavailability after oral administration means that berberine has an intense local effect in the intestine, where it is metabolized with the participation of the microbiota,” explains Dr. Duda-Madej.

During this local metabolism, microbes in the gut may transform berberine into biologically active compounds. These products can alter the intestinal environment, which may indirectly contribute to the metabolic effects observed in some studies.

Why the “universal supplement” is a myth

The review’s author strongly rejects the simplified way berberine is sometimes portrayed in media coverage.

“The term ‘universal metabolic supplement’ is completely inaccurate,” she emphasizes. “A more appropriate term would be: modulator of the gut-microbiota-immune system axis,” notes Dr. Duda-Madej.

She also highlights safety concerns that are often ignored in online discussions.

“According to information provided by the National Center for Complementary and Integrative Health, the use of berberine is primarily associated with adverse effects on the gastrointestinal tract, such as nausea, abdominal pain, bloating, constipation, and diarrhea. Importantly, berberine interacts with many drugs by inhibiting enzymes involved in their metabolism, including cyclosporine, metformin, antidiabetic drugs, anticoagulants, and sedatives. In addition, it can be dangerous during pregnancy and breastfeeding, as it can affect the fetus or infant, leading to bilirubin accumulation and the risk of brain damage. For this reason, berberine should be used with great caution and only under medical supervision,” the author emphasizes.

From a scientific perspective, berberine should not be viewed as a replacement for prescription medications or as a universal natural remedy. Instead, researchers see it as a useful tool for studying how closely human metabolism is tied to the gut and how strongly metabolic processes depend on interactions with the microbiota.

Reference: “Berberine in Bowel Health: Anti-Inflammatory and Gut Microbiota Modulatory Effects” by Anna Duda-Madej, Szymon Viscardi, Jakub Piotr Łabaz, Ewa Topola, Wiktoria Szewczyk and Przemysław Gagat, 12 December 2025, International Journal of Molecular Sciences.
DOI: 10.3390/ijms262412021